InVivo Therapeutics (OTC:NVIV) and its former CEO are facing a possible class-action lawsuit alleging that they concealed the truth about how long a clinical trial would take.
InVivo, co-founded by Reynolds based on technology out of MIT professor Robert Langer’s lab, is developing a treatment for spinal cord injury.
Reynolds, who was chairman, CFO & CEO, left InVivo suddenly in August 2013, citing a “medical condition.” Back in 2009 and 2010, Reynolds told MassDevice.com and Inc. magazine that he’d suffered spinal cord injury of his own in a 1992 car accident that left him partially paralyzed.
Help employers find you! Check out all the jobs and post your resume.
